Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Closes
- Nov 16, 2027 (in 474 days)
Similar opportunities open now
- Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)OpenNational Institutes of HealthCloses Nov 2027
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)OpenNational Institutes of HealthCloses Mar 2027Up to $1.5M
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)OpenNational Institutes of HealthCloses Mar 2027
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)OpenNational Institutes of HealthCloses Jan 2027
- Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Jan 2028Up to $200K
Classification and identifiers
- Solicitation number
- PAR-25-068
- Assistance listing (CFDA)
- 93.847
Amount
Amount not published by the funder
Who can apply
State government agencies and Private colleges and universities can all apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as de...
About this opportunity
This Notice of Funding Opportunity (NOFO) invites applications for innovative basic and translational pilot research projects within the mission of the NIDDK that are aligned with NIH HIV/AIDS research priorities. These priorities were most recently outlined by the NIH Office of AIDS Research (OAR) in NOT-20-018, UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding, scientific priorities. Potential topics could address multiple overarching priorities. These include elucidation of unique pathophysiological mechanisms contributing to HIV comorbidities, coinfections, and complications (CCCs) affecting organs, tissues, and processes within the mission of the NIDDK. Likewise, interrogations into biological mechanisms underlying HIV reservoirs in NIDDK-relevan...
Related opportunities
- Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)National Institutes of HealthCloses Nov 2027
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)National Institutes of HealthCloses Mar 2027Up to $1.5M
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)National Institutes of HealthCloses Mar 2027
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)National Institutes of HealthCloses Jan 2027
- Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)National Institutes of HealthCloses Jan 2028Up to $200K
- Focused Technology Research and Development (R01 Clinical Trial Not Allowed)National Institutes of HealthCloses Jan 2028